Cargando…
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours
PURPOSE: To determine the utility of the 2022 WHO Classification of pituitary tumours in routine clinical practice and to develop an optimal diagnostic algorithm for evaluation of tumour type in a real-world setting. METHODS: Retrospective evaluation of pituitary tumour immunohistochemistry (IHC), o...
Autores principales: | Lenders, N. F., Chui, J., Low, J., Inder, W. J., Earls, P. E., McCormack, A. I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675696/ https://www.ncbi.nlm.nih.gov/pubmed/36271964 http://dx.doi.org/10.1007/s11102-022-01284-2 |
Ejemplares similares
-
Transcription Factor Immunohistochemistry in the Diagnosis of Pituitary Tumors
por: Lenders, Nele F, et al.
Publicado: (2021) -
The evolution in pituitary tumour classification: a clinical perspective
por: Lenders, Nele F, et al.
Publicado: (2023) -
Refractory Pit1 plurihormonal tumours and thyrotroph adenomas
por: NF, Lenders, et al.
Publicado: (2023) -
Pituitary hyperplasia: case series and literature review of an under-recognised and heterogeneous condition
por: De Sousa, Sunita M C, et al.
Publicado: (2015) -
Costs and Its Determinants in Pituitary Tumour Surgery
por: Dekkers, Alies J., et al.
Publicado: (2022)